The 20 Best Bladder Cancer Doctors Near Me in Vienna, 9

Armine Smith, M.D. is the director of urologic oncology at the Kimmel Cancer Center at Sibley Memorial Hospital, and an associate clinical professor of urology at the Brady Urological Institute of Johns Hopkins University School of Medicine. She is a member of Greenberg Bladder Cancer Institute and the director of Women's Bladder Cancer Program at Sibley Memorial Hospital. She is also a Mary and Armeane Choksi Scholar. Dr. Smith earned her medical degree from the University of California in San Francisco. She completed a residency in urology at the Cleveland Clinic, followed by a fellowship in urologic oncology at the National Cancer Institute, where she focused on development of personalized targeted therapies for bladder cancer. Dr. Smith is a member of the Society of Urologic Oncology, American Association of Cancer Research and American Urological Association. She has been selected multiple times as a Washington, DC and Virginia top urologist. Dr. Smith specializes in advanced open, minimally invasive and robotic urologic surgery for urologic malignancies, including bladder and upper tract urothelial cancer, kidney cancer, testicular cancer, penile and urethral cancer. In bladder cancer surgery she specializes in bladder preservation, complex urinary diversions, including continent orthotopic neobladder and continent catheterizable Indiana pouch techniques. In kidney cancer, her expertise focuses on partial nephrectomy, with the goal of oncologically-sound maximum nephron-sparing surgery. She has contributed to various research, publications and presentations on topics of urology. Dr. Smith has made TV appearances, lectured domestically and internationally, and authored chapters on urothelial and kidney cancer. Her current research focuses on elucidation of risk factors for bladder cancer development, oncologically safe organ preservation in both men and women with bladder and kidney cancer and improving outcomes from bladder cancer treatments. Listen to Dr. Smith’s Cancer Matters podcast episode to learn more about her work. Dr. Smith is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Smith is board certified in American Board Of Urology.

Christopher Rothstein is an Interventional Radiologist practicing medicine in Mc Lean, Virginia. Dr. Rothstein is rated as an Advanced provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Smoldering Multiple Myeloma, Urothelial Cancer, Bladder Cancer, Bone Graft, and Vertebroplasty.

Nicholas Lailas is a Urologist practicing medicine in Reston, Virginia. Dr. Lailas is rated as an Advanced provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Prostate Cancer, UPJ Obstruction, Ureteroscopy, and Reconstructive Urology Surgery.

Wohlscheid Director, Genitourinary Oncology Research Inova Schar Cancer Dr. Jeanny B. Aragon-Ching, MD, FACP, serves as the Clinical Program Director of Genitourinary Cancers at the Inova Schar Cancer Institute with a joint academic appointment as Associate Professor of Medical Education at the University of Virginia. Dr. Aragon-Ching joined Inova Schar Cancer Institute in 2015 to spearhead the GU Oncology program and bring together multidisciplinary expertise and advancement of research, clinical trial development, and personalized clinical care of patients with GU cancers. She has since served in the ASCO GU Program Planning Committee from 2017-2019, served as Track Chair for Urothelial cancers in 2018 and Renal Cell Cancer Track in 2016–2017 and member of the Prostate cancer track. She has chaired different sessions on bladder urothelial and non-urothelial cancers, kidney and prostate cancers. She also served in the ASCO Cancer Education Committee for the annual meeting for the GU non-prostate cancers. She is dedicated to the research and clinical care of patients with genitourinary cancers. Dr. Aragon-Ching completed her internship and residency at the Albert Einstein Medical Center in Philadelphia, PA, where she served the final year as Chief Resident. She later completed a Medical Oncology Fellowship at the National Cancer Institute, National Institutes of Health, in Bethesda, MD, where she served as an Associate Investigator on varying trials involved with pharmacogenomics and early drug discovery for genitourinary tumors. Dr. Aragon-Ching later moved to the George Washington University Medical Center in 2008 and was promoted to the rank of Associate Professor of Medicine in 2014. Her early research work focused on the use of angiogenesis inhibitors, bone-targeted agents, circulating tumor cells, clinical trial design and drug development. She has served in varying capacities as a peer reviewer, editorial board member and expert panel for highly acclaimed journals and congressionally directed research program grants. She is a well-published author and investigator of multiple GU trials, including prostate cancer, bladder cancer and kidney cancer trials. She is a well-established educator and serves on the editorial board of various academic journals. Dr. Aragon-Ching has chaired national meetings at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium and has delivered esteemed presentations at the Society of Urologic Oncology, Best of ASCO, AUA, EAU, and the ASCO Annual meeting. She has also been previously named a “Top Doctor” by Washingtonian magazine and a “Best Doctor” by the Northern Virginia magazine. Dr. Aragon is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Urothelial Cancer, Bladder Cancer, Orchiectomy, and Prostatectomy.

Dr. Simon Chung is a specialty care physician board certified in urology at Inova Health System. Dr. Chung joined Inova in 2014 and has been practicing since 1993. He served as an active medical staff member at Inova Fairfax Hospital and served as the hospital’s Urology Section Chief until 2022. Prior to joining Inova, Dr. Chung was the Rotation Site Director for George Washington University’s urology residency program from 1993 to 2013 and was honored four times by the residents with an Excellence in Teaching Award. He has been named to “Top Doctor” lists in several regional publications since entering his practice and earned national recognition on the Castle Connolly Top Doctors list. Dr. Chung’s clinical areas of interest include urological cancers, stone disease, and minimally invasive and robotic surgeries. He was among the first surgeons worldwide, in 2004, to perform robotic-assisted laparoscopic surgery and has accumulated a varied and extensive experience to safely treat cancers, anatomic abnormalities and traumatic injuries of the urinary system. He has devised kidney-sparing cancer surgery (robotic-assisted laparoscopic partial nephrectomy) strategies for complex kidney tumor removal that otherwise would result in unnecessary loss of the entire kidney. Dr. Chung has assisted in the development and growth of robotic surgery programs in gynecology, colorectal surgery, general surgery, otorhinolaryngology, pediatric surgery and transplant surgery at Inova. In consideration of these efforts, Dr. Chung was designated System Medical Director of Robotics for Inova in 2022. Dr. Chung is proud of his patient-centric approach to healthcare delivery, emphasizing patient education with plain language discussions and shared decision making. The “Golden Rule” (do unto others…) applies to his patient care philosophy. Outside his medical world, Dr. Chung spends as much time with his family and close friends as possible. He is a lifelong builder of radio-controlled model aircraft and model rockets. Someday, he’ll get them off the ground again. Dr. Chung is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Familial Prostate Cancer, Prostate Cancer, Vasectomy, and Reconstructive Urology Surgery.

Dr. Sekwon Jang is a specialty care physician board certified in internal medicine, hematology, and medical oncology. He has a special interest in management of melanoma and other skin cancers including cutaneous lymphoma. Dr. Jang serves as Director of Melanoma and Cutaneous Oncology Therapeutics and Research and Director of Quality at the Inova Schar Cancer Institute. Before joining Inova, Dr. Jang served as Assistant Professor of Medicine at Georgetown University School of Medicine and Co-Chair of melanoma research group at MedStar Georgetown Cancer Network. Dr. Jang believes in a covenant relationship with his patients, and his goal is to provide the best quality patient-centered care in the setting of multidisciplinary collaboration. Dr. Jang is rated as an Advanced provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Squamous Cell Skin Carcinoma, and Eccrine Porocarcinoma.

Dr. Kathleen Sterling is part of the Suburban Hospital’s medical staff and a urologist with Urological Consultants, P.A. Dr. Sterling served as chief resident of the University of Maryland Medical Center urology program. During her training, she performed laboratory research related to overactive bladder. With an undergraduate degree from Vanderbilt University, Dr. Sterling served as a Surface Warfare Officer in the United States Navy, completing two deployments at sea, including one combat mission during Operation Iraqi Freedom. Dr. Sterling treats both men and women. Her expertise includes voiding dysfunction, male and female urinary incontinence and female pelvic floor disorders. Dr. Sterling’s practice also encompasses medical and surgical management of kidney stones, erectile dysfunction and urological cancers. Dr. Sterling sees patients in Bethesda and Germantown, Maryland. For appointments, call 301-530-1700. Dr. Sterling is rated as an Advanced provider by MediFind in the treatment of Bladder Cancer. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Urinary Incontinence, Kidney Stones, and Ureteroscopy. Dr. Sterling is board certified in American Board Of Urology.

Kambiz Tajkarimi is a Urologist practicing medicine in Mclean, Virginia. Dr. Tajkarimi is rated as an Experienced provider by MediFind in the treatment of Bladder Cancer. His clinical expertise encompasses Enlarged Prostate (BPH), Erectile Dysfunction (ED), Urothelial Cancer, Reconstructive Urology Surgery, and Ureteroscopy.

Christina Brzezniak is a Hematologist and an Oncologist practicing medicine in Reston, Virginia. Dr. Brzezniak is rated as an Experienced provider by MediFind in the treatment of Bladder Cancer. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses HER-2 Positive Breast Cancer, Myeloproliferative Neoplasms (MPN), Lung Cancer, and Paget Disease of the Breast.

John Ruff is a Radiologist practicing medicine in Fairfax, Virginia. Dr. Ruff is rated as an Experienced provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Pleurisy, Pleural Effusion, Pulmonary Fibrosis, Visceromegaly, and Bone Marrow Aspiration.

Daniel Overdeck is a Radiologist practicing medicine in Fairfax, Virginia. Dr. Overdeck is rated as an Experienced provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Gallbladder Disease, Lung Nodules, Ascites, Pleurisy, and Bone Marrow Aspiration.

Karen Riedy is a Radiologist practicing medicine in Fairfax, Virginia. Dr. Riedy is rated as an Experienced provider by MediFind in the treatment of Bladder Cancer. She is also highly rated in 35 other conditions, according to our data. Her clinical expertise encompasses Pleurisy, Pleural Effusion, Progressive Familial Intrahepatic Cholestasis Type 1, and Progressive Familial Intrahepatic Cholestasis Type 3.

Dr. Rosenblum is originally from Mexico City. He received his medical degree from the Anahuac University where he graduated at the top of his class. He then competed for and was awarded a urology residency position at the prestigious National Institute of Medical Sciences in Mexico. He subsequently accepted a fellowship position in urologic oncology at the University of Colorado Health Sciences Center in Denver, where he was involved in multiple research projects relating to urologic cancers–in particular, prostate cancer treatments and prostate cancer chemoprevention. Upon completing his fellowship, Dr. Rosenblum emigrated to the United States and became board eligible by completing his second urology residency at the Washington Hospital Center in Washington, D.C. He is a diplomate of the American Board of Urology. Dr. Rosenblum has been in private practice since 2005. He also volunteers as a consultant for the Montgomery County Cancer Crusade. He has a diverse urologic practice with particular interests in minimally invasive surgery for urologic cancers. Dr. Rosenblum has published multiple journal articles and meeting abstracts, and he has been an invited lecturer both here and abroad. He has received multiple awards and distinctions along the course of his career. Dr. Rosenblum is a member of the American Urological Associationand a Fellow of the American College of Surgeons. When he is not caring for patients, Dr. Rosenblum enjoys spending time with his wife, two small daughters, and his dog, Lucas. Dr. Rosenblum is rated as an Advanced provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Familial Prostate Cancer, Prostate Cancer, Ureteroscopy, and Nephrectomy. Dr. Rosenblum is board certified in American Board Of Urology.

Mark Goldstein is a Hematologist Oncology provider practicing medicine in Bethesda, Maryland. Dr. Goldstein is rated as an Experienced provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Anal Cancer, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma. Dr. Goldstein is board certified in American Board Of Internal Medicine.

Andrew Joel is a Urologist practicing medicine in Arlington, Virginia. Dr. Joel is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Reconstructive Urology Surgery.

Robert Mordkin is a Urologist practicing medicine in Arlington, Virginia. Dr. Mordkin is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Prostate Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and a professor of oncology at the Johns Hopkins University School of Medicine. She practices out of the Prostate Cancer Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, D.C., and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. Dr. Paller has expertise in prostate, bladder, kidney, and testicular cancer. Dr. Paller earned her medical degree from Harvard Medical School and completed a residency in internal medicine, followed by a fellowship in hematology and oncology at Johns Hopkins University School of Medicine. In addition, Dr. Paller completed a rotation with the chief of the Investigational Drug Branch at the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and a rotation with the associate director for regulatory science in the Office of Oncology Drug Products at the Food and Drug Administration. She also completed rotations at the Weizmann Institute of Israel’s Department of Biological Regulation and McCord Hospital in South Africa, where she participated in the Harvard AIDS project. In 2016, Dr. Paller was one of only five oncologists awarded the NCI Mentored Patient-Oriented Research Career Development Award. In 2015, she received the 2015 Passano Clinician Scientist Award for early-stage research that is already making a contribution to science. Earlier in her career, she was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and for the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award. Dr. Paller is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Paller’s research focuses on evaluating new therapies for prostate cancer, particularly combination therapies that engage the immune system. She is the principal investigator on two multi-site clinical trials and was the first author on the NCI Investigational Drug Steering Committee publication, “Consensus Recommendations on the Phase I Combination Clinical Trials of the Clinical Trial Design Task Force.” Dr. Paller was the chair for the oral abstract session on genitourinary cancer at the 2015 Annual Meeting of the American Society of Clinical Oncology and she is currently funded by an NCI immunotherapy grant to look at combination therapies that link standard of care therapy with inhibition of transforming growth factor beta in prostate cancer. She is also opening trials of vitamin C with chemotherapy in prostate cancer and of mistletoe in all solid tumors. Dr. Paller is rated as an Experienced provider by MediFind in the treatment of Bladder Cancer. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Paller is board certified in American Board Of Internal Medicine.

Noah Schenkman is a Urologist practicing medicine in Mc Lean, Virginia. Dr. Schenkman is rated as an Experienced provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Perirenal Abscess, Boils, Retroperitoneal Fibrosis, Nephrectomy, and Reconstructive Urology Surgery.

Timothy Kim is a Urologist practicing medicine in Mclean, Virginia. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Urothelial Cancer, Prostate Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Gary Fialk is a Urologist practicing medicine in Reston, Virginia. Dr. Fialk is rated as an Experienced provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Kidney Stones, Boils, Folliculitis, Ureteroscopy, and Prostatectomy.